Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Sawai Pharmaceutical's operating income FY 2006-2016

Operating income of Sawai Pharmaceutical Co., Ltd. from fiscal year 2006 to 2016 (in billion Japanese yen)

by Statista Research Department, last edited Jan 31, 2018
Sawai Pharmaceutical's operating income FY 2006-2016 The statistic illustrates the operating income of Sawai Pharmaceutical Co., Ltd. from fiscal year 2006 to 2016. In fiscal year 2016, the Japanese generics manufacturer Sawai's operating income amounted to roughly 20.6 billion Japanese yen, down from about 23.2 billion yen in fiscal 2015.
Show more

Operating income of Sawai Pharmaceutical Co., Ltd. from fiscal year 2006 to 2016 (in billion Japanese yen)

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Pharmaceutical trends in Europe"
  • Overview
The most important statistics
  • European Pharmaceutical companies
  • Self-medication market
  • Employment
  • Clinical Trials
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.